National Comp Conference & Tradeshow

Event Details

Start: November 11, 2025 @ 8:00AM EST On-Demand End: November 12, 2025 @ EST On-Demand Location: Music City Center, Nashville, TN

National Comp is the only national conference devoted to Workers’ Compensation and Disability Management Professionals. This conference also highlights the largest expo in the Workers’ Comp industry, drawing approximately 5,000 attendees each year.

Enlyte will have a dynamic exhibit display on the show floor at Booth #1512 and is happy to be a returning diamond sponsor for this years’ conference. Enlyte will also be featured in the following sessions during the conference (*agenda subject to change).

Session Name: Change the Mental Health Conversation: Practical Paths to Workplace Resilience
Date and time: November 11 at 1:15 pm in Session Room 3

Session Name: Demystifying PBMs in Comp: Navigating the Good, the Bad and the Essential
Date and time: November 11 at 2:30 pm in the National Comp Theater

Session Name: One Team, Better Outcomes: FedEx's Risk Management Integration
Date and time: November 12 at 1:15 pm in the Industry Theater

Additionally, Enlyte is hosting a special reception at Country Music Hall of Fame on Monday, November 10 from 6:00 pm - 8:30 pm to kick off the National Comp Conference. Please contact your sales or customer success manager for more information.

More stories

Workers' Comp Podcast

Peter Rousmaniere Part 2: Trends and Advice for Comp

December 18, 2019

We’re back with the second part of our exclusive interview with Peter Rousmaniere in which he discusses how current trends will impact the future of the industry and gives us a preview of what he plans to do next after his retirement from workers’ comp. Here’s part 2.

Mitchell News Release

Mitchell Diagnostics System Enhanced for FCA Secure Gateway and Turbo-Speed Scanning

December 18, 2019

Mitchell's all-makes scan tools from Bosch offer full access to FCA secure vehicle networks and dramatic speed improvements for pre- and post-scanning.

Workers' Comp Blog

Warnings about impurities in Zantac® and blood pressure medicines

December 16, 2019

In September 2019, the U.S. Food and Drug Administration (FDA) reported the discovery of low levels of an impurity in brand, generic, and over- the-counter (OTC) versions of a popular heartburn medication, Zantac® (Ranitidine HCl) 1, prompting a flurry of manufacturer recalls, national distribution halts, and product removals from retail pharmacy shelves. Ranitidine is an H2 (Histamine-2) blocker approved as a prescription medicine for treatment and prevention of GI ulcers and gastroesophageal reflux disease (GERD). OTC versions are approved for relief of acid indigestion and sour stomach. H2 blockers (like Tagamet, Pepcid, and Zantac) act by reducing the amount of acid produced by cells lining the stomach.

Workers' Comp Podcast

Peter Rousmaniere Part 1: Comp’s Evolutions and Influencers

December 12, 2019

When you think of industry icons in workers’ comp, Peter Rousmaniere is among the select few at the top of the list. For more than 30 years, Peter has been a major influencer in workers’ comp, especially over the past couple of decades as a popular columnist. Last month, Peter announced his well-deserved retirement, so we asked him to join us on Inside Workers’ Comp to talk about his celebrated career and offer insights on the industry. The conversation was so profound that we made it into a two-parter. Here’s Part 1.

Mitchell News Release

Mitchell Issues 4th Quarter 2019 Industry Trends Report

December 10, 2019

The impact of emotion AI on “humane” claims automation; the complexities of windshield repair; and actionable insights for maximizing value of claims data and analytics.

Workers' Comp Blog

What moved the state of Ohio to drop OxyContin® from their formulary?

December 9, 2019

The state of Ohio, among the hardest hit in the nation for opioid overdose deaths, has undertaken a number of measures to meet the crisis as it has evolved. A review of opioid use in the injured worker population, completed in 2011, revealed an alarming number (73%) were filling opioid prescriptions.1 A closed formulary, expanded access to antidote products (naloxone), and opioid focused prescribing guidelines have all followed since and have contributed to some reductions in prescribing and the prevalence of opioid use.